Susquehanna Portfolio Strategies, LLC Allakos Inc. Transaction History

Susquehanna Portfolio Strategies, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$1.0 - $1.45 $74,646 - $108,236	-74,646 Reduced 46.34%	86,431 $86.4 Million
Q1 2024 May 07, 2024	SELL	$1.02 - $3.23 $135,735 - $429,829	-133,074 Reduced 45.24%	161,077 $203 Million
Q4 2023 Feb 14, 2024	BUY	$1.72 - $3.18 $505,939 - $935,400	294,151 New	294,151 $803 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $74.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Susquehanna Portfolio Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Portfolio Strategies, LLC with notifications on news.